Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy

Background: EPIC1 is an oncogenic long non-coding ribonucleic acid (RNA) that promotes cell growth and cell-cycle progression and inhibits apoptosis in several cancer cell lines. However, clinical studies on EPIC1 in breast cancer, specifically in the neoadjuvant setting, are relatively few. Methods...

Full description

Bibliographic Details
Main Authors:	Yaqian Xu, Yan Wang, Chenwei Yuan, Xiaonan Sheng, Rui Sha, Huijuan Dai, Shan Zhang, Yaohui Wang, Yanping Lin, Liheng Zhou, Shuguang Xu, Jie Zhang, Wenjin Yin, Jinsong Lu
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-07-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758835920940886

Similar Items

Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy
by: Rui Sha, et al.
Published: (2021-09-01)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
by: Ziping Wu, et al.
Published: (2019-03-01)

Association of Neo-Family History Score with pathological complete response, safety, and survival outcomes in patients with breast cancer receiving neoadjuvant platinum-based chemotherapy: An exploratory analysis of two prospective trials
by: Yaqian Xu, et al.
Published: (2021-08-01)

Linc00665 Can Predict the Response to Cisplatin-Paclitaxel Neoadjuvant Chemotherapy for Breast Cancer Patients
by: Huijuan Dai, et al.
Published: (2021-03-01)

Serum miR-222-3p as a Double-Edged Sword in Predicting Efficacy and Trastuzumab-Induced Cardiotoxicity for HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Target Therapy
by: Shan Zhang, et al.
Published: (2020-04-01)

Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer
by: Battseren Bayarmaa, et al.
Published: (2019-09-01)

HIF1α Regulates IL17 Signaling Pathway Influencing Sensitivity of Taxane-Based Chemotherapy for Breast Cancer
by: Huijuan Dai, et al.
Published: (2021-09-01)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
by: Cao Maria D, et al.
Published: (2012-01-01)

The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
by: Toshiaki Iwase, et al.
Published: (2021-02-01)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
by: Ileana Corbeau, et al.
Published: (2020-09-01)

LncRNA CARMN overexpression promotes prognosis and chemosensitivity of triple negative breast cancer via acting as miR143-3p host gene and inhibiting DNA replication
by: Xiaonan Sheng, et al.
Published: (2021-06-01)

Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma
by: Denise Willmer, et al.
Published: (2021-04-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease
by: Jing Li, et al.
Published: (2017-08-01)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
by: Fei Ji, et al.
Published: (2021-10-01)

Survival outcomes of locally advanced gastric cancer cases with pathological complete response received neoadjuvant chemotherapy
by: Qing Hu, et al.
Published: (2021-06-01)

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
by: Mozhi Wang, et al.
Published: (2021-04-01)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
by: Icro Meattini, et al.
Published: (2014-01-01)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Li Chen, et al.
Published: (2021-03-01)

Prognostic factors for survival among gastric cancer patients receiving neoadjuvant chemotherapy: A cross sectional study from Turkey
by: Orhan Uzun, et al.
Published: (2020-11-01)

Tissue Biomarkers in Prognostication of Serous Ovarian Cancer following Neoadjuvant Chemotherapy
by: Binny Khandakar, et al.
Published: (2014-01-01)

Lymphocyte-to-Monocyte Ratio is Associated with the Poor Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
by: Ma Y, et al.
Published: (2021-02-01)

SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer
by: Lei Zhang, et al.
Published: (2020-08-01)

Real-World Effectiveness and Prognostic Factors Analysis of Stages I-III Non-Small Cell Lung Cancer Following Neoadjuvant Chemo-Immunotherapy or Neoadjuvant Chemotherapy
by: Gao, Z., et al.
Published: (2022)

Incidence of chemotherapy-induced neutropenia in HIV-infected and uninfected patients with breast cancer receiving neoadjuvant chemotherapy
by: Sithembile Ngidi, et al.
Published: (2017-07-01)

Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
by: Jing Li, et al.
Published: (2016-01-01)

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy
by: Wangqiang Jia MD, et al.
Published: (2021-07-01)

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?
by: Nicole M. Melchior, et al.
Published: (2020-04-01)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
by: Juan Sun, et al.
Published: (2021-04-01)

Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
by: Xu W, et al.
Published: (2020-06-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
by: Anna Jakabova, et al.
Published: (2021-07-01)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
by: Fasching Peter A, et al.
Published: (2011-11-01)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
by: Jian-Wei Xie, et al.
Published: (2021-07-01)

Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013)

Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)

Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
by: Yu-Ge Bai, et al.
Published: (2020-03-01)

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-09-01)

Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response
by: Uanderson Resende, et al.
Published: (2019-06-01)

Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance
by: Cetina Lucely, et al.
Published: (2005-06-01)